Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2010
12/23/2010WO2010147978A1 Dosage forms of apixaban
12/23/2010WO2010147899A1 Stable nanoparticulate drug suspension
12/23/2010WO2010147831A1 Dendrimer based nanodevices for therapeutic and imaging purposes
12/23/2010WO2010147632A1 Microgel compositions and methods
12/23/2010WO2010147387A2 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides as active ingredients
12/23/2010WO2010147169A1 Pharmaceutical composition having improved solubility
12/23/2010WO2010147158A1 Gel enclosing a compound by means of low-molecular weight gelling agent
12/23/2010WO2010147144A1 Oral liquid preparation
12/23/2010WO2010146872A1 Composition for external application comprising aripiprazole and organic acid as active ingredients
12/23/2010WO2010146845A1 Soft capsule and manufacturing method therefor
12/23/2010WO2010146606A1 Nanodispersion of a drug and process for its preparation
12/23/2010WO2010146601A1 Rapid dissolvable oral film for delivering herbal extract/s with or without other pharmaceutically active agents
12/23/2010WO2010146574A1 Solid forms for tissue repair
12/23/2010WO2010146551A2 Orally disintegrating compositions comprising antihypertensive agents
12/23/2010WO2010146536A1 Suspension of particles with drug
12/23/2010WO2010146478A1 Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
12/23/2010WO2010146409A2 Nanoparticulate candesartan cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them
12/23/2010WO2010146408A2 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
12/23/2010WO2010146407A1 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
12/23/2010WO2010146406A1 Nanoparticulate telmisartan compositions and process for the preparation thereof
12/23/2010WO2010146394A1 Theobromine for the treatment of cough
12/23/2010WO2010146179A2 Solid pharmaceutical composition comprising rivaroxaban
12/23/2010WO2010146171A1 Novel manner of administering allergen in allergen specific immunotherapy
12/23/2010WO2010146155A1 Gelled iron veterinary suspension
12/23/2010WO2010145849A2 Drug delivery systems
12/23/2010WO2010145653A1 Buffered gum base for high ph release
12/23/2010WO2010145192A1 Mangiferin-berberine salt, manufacturing method and use thereof
12/23/2010WO2010145066A1 Compositions of sulfodehydroabietic acid disodium salt for preventing or treating hyperacid gastroenteritis and peptic ulcers and preparation methods thereof
12/23/2010WO2010145017A1 Stimulation of innate immunity with an antigen from bacterial origin
12/23/2010WO2010144943A1 Buccal and/or sublingual therapeutic formulation
12/23/2010WO2010123946A3 Silk fibroin hydrogels and uses thereof
12/23/2010WO2010116336A8 Uses of red yeast rice in treating dengue virus infection
12/23/2010WO2010109021A3 Implantable medical devices coated with nucleic acid-encapsulating liposome
12/23/2010WO2010100658A3 Stable olanzapine tablets and the process for its preparation
12/23/2010WO2010095158A8 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
12/23/2010WO2010082219A4 An arteether injection for treatment of malaria
12/23/2010WO2010072640A9 Method for stabilizing polymers
12/23/2010WO2010064126A3 Controlled release dosage forms
12/23/2010WO2010063630A3 Pancreatic tumour treatment
12/23/2010WO2010056598A3 Biodegradable alpha-2 adrenergic agonist polymeric implants
12/23/2010WO2010055477A4 Cell piercing device and method of using the same
12/23/2010WO2010049433A3 Water insoluble polymer: starch-based film coatings for colon targeting
12/23/2010WO2010037854A3 Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules
12/23/2010WO2010020798A3 Nanoparticles
12/23/2010WO2009122252A3 Dental composition for treating peri-imlantitis
12/23/2010WO2009090558A3 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
12/23/2010US20100324646 Biodegrdable Medical Device With Hydroxyapatite Filaments and Biodegradable Polymer Fibers
12/23/2010US20100324564 Particles, grains or granules for the treatment of an injured vertebra
12/23/2010US20100324500 Bone-Replacement Materials, Methods and Devices
12/23/2010US20100324126 Syn3 compositions and methods
12/23/2010US20100324100 Sustained release aminopyridine compositions
12/23/2010US20100324099 Sustained release aminopyridine compositions
12/23/2010US20100324098 Sustained release aminopyridine compositions
12/23/2010US20100323987 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
12/23/2010US20100323986 Compositions and methods for modulation of vascular structure and/or function
12/23/2010US20100323167 Indented antimicrobial paper and a process for making and using the same
12/23/2010US20100323091 Methods To Increase Fracture Resistance Of A Drug-Eluting Medical Device
12/23/2010US20100323090 Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient
12/23/2010US20100323038 Pharmaceutical Compositions
12/23/2010US20100323026 Sustained release preparation for tissue regeneration therapy
12/23/2010US20100323025 Timed-release pharmaceutical preparation
12/23/2010US20100323024 Puumala virus full-length m segment-based dna vaccines
12/23/2010US20100323023 Composition for the treatment of a detached retina and method of production thereof
12/23/2010US20100323022 Calcium phosphate composition and process for production thereof
12/23/2010US20100323021 Antitumoral treatments
12/23/2010US20100323020 Stable nanoparticulate drug suspension
12/23/2010US20100323019 Microparticles for the treatment of disease
12/23/2010US20100323018 Branched DNA/RNA monomers and uses thereof
12/23/2010US20100323017 Escitalopram and Solid Pharmaceutical Composition Comprising the Same
12/23/2010US20100323016 Modified release formulation and methods of use
12/23/2010US20100323015 Modified release formulation and methods of use
12/23/2010US20100323014 Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
12/23/2010US20100323013 Hydrolysates made of plant extracts and antibacterial agent containing the same
12/23/2010US20100323012 Pharmaceutical Compositions Comprising NEP-Inhibitors, Inhibitors of the Endogenous Endothelin Producing System and Diuretics
12/23/2010US20100323011 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
12/23/2010US20100323010 Formulation and process for drug loaded cores
12/23/2010US20100323008 Solid dosage form comprising a fibrate
12/23/2010US20100323007 A polyamide rate-modulated monolithic drug delivery system
12/23/2010US20100323006 Pharmaceutical solid preparation comprising benzazepines and production method thereof
12/23/2010US20100323005 Sodium Ibuprofen Tablets and Methods of Manufacturing Pharmaceutical Compositions Including Sodium Ibuprofen
12/23/2010US20100323004 Non-pegylated liposomal doxorubicin triple combination therapy
12/23/2010US20100323003 Flaviviridae Mutants Comprising a Deletion in the Capsid Protein for Use as Vaccines
12/23/2010US20100323002 Inhibition of melanogenesis and melanoma metastasis with p-amino benzoic acid (paba)
12/23/2010US20100323001 In Vivo Delivery Of Double Stranded RNA To a Target Cell
12/23/2010US20100323000 Method and process for preparing cardiolipin
12/23/2010US20100322999 Fentanyl-containing patch for external use
12/23/2010US20100322997 Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same
12/23/2010US20100322996 Fluid Absorbent Adhesive Articles
12/23/2010US20100322994 Particulate cartilage system
12/23/2010US20100322993 Injectable biocompatible composition
12/23/2010US20100322991 Honokiol analogs and their use in treating cancers
12/23/2010US20100322985 Effervescent compositions
12/23/2010US20100322982 Alloplastic injectable dermal filler and methods of use thereof
12/23/2010US20100322980 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
12/23/2010US20100322979 Peptidomimetic Resorbable Peptide-Polymer Hybrid Polyester Nanoparticles
12/23/2010US20100322978 Medical composition
12/23/2010US20100322908 Compositions and methods for augmentation and regeneration of living tissue in a subject
12/23/2010US20100322902 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
12/23/2010US20100322871 Co-polymer Stabilizers For Hydryfluoroalkane Dispersions
12/23/2010US20100322862 Methods and compositions using peptides and proteins with c-terminal elements
1 ... 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 ... 2991